Coverage
-
December 18, 2013
Radient Pharmaceuticals Corp. has agreed to pay $2.5 million to settle a class action brought by investors who allege the company falsely claimed to have a clinical testing partnership with the prestigious Mayo Clinic, according to a motion filed Tuesday in California federal court.
1 other articles on this case.
View all »